Companies · Other Health Care

Clear Choice ER, LLC

Laredo · Other Health Care

Diligence memoA one-page analyst read on Clear Choice ER, LLC — recommendation, valuation, rhythm, risks.
$8.3M
Total raised · real
3
Rounds
0.2×
Latest step-up
Top 28%
Sector rank · raised
Series A
Latest stage · inferred · Fri Jan 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Clear Choice ER, LLC looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.25× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era.
Active
  • Last raise 17 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Clear Choice ER, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
7.0 yr record
Peak capital year was 2024 with $6.0M across 1 filings.
Market position
ahead of 73% of Other Health Care peers
Capital scale is ahead of 73% of Other Health Care peers; modeled value is above 18% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2024: $6.0M across 1 filings.
  • Largest single filing was $6.0M on 2024-12-03.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Clear Choice ER, LLC is one of 5376 Other Health Care companies tracked from Laredo. By capital raised it ranks in the upper tier (ahead of 73% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2025-01-31
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MSeed · 2019-07-01 Raised $1.2M (real) Modeled valuation $30M (est)$1.2M$30MSeed2019Series A · 2024-12-03 Raised $6.0M (real) Modeled valuation $25M (est)$6.0M$25MSeries A2024Series A · 2025-01-31 Raised $1.1M (real) Modeled valuation $4.1M (est)$1.1M$4.1MSeries A2025+$6.0M+$1.1MCumulative $8.3M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.2M · 2019
Series A$6.0M · 2024
Series A extension$1.1M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$4.1M
Base estimate est.
$1.3M
Conservative case
$7.7M
Upside case
$4.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $30.4M · 2019-07-012019Series A · modeled $24.8M · 2024-12-03Series A · modeled $4.1M · 2025-01-312025
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
1.4 yr
Elapsed time used
1.4 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
34 mo
Avg between rounds
$1.5M/yr
Capital velocity
7.0 yr
On record since
2019
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 3.4× above median
This company$8.3M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.2× of median
This company$1.1M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$4.1M
Sector median$22.1M

Raised more than 73% of sector peers (real $). Modeled value above 18% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #70 of 83.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)HelloJoy, Inc. · Series A Raised $26.3M · modeled $55.0M (est)Maui Imaging, Inc. · Series A Raised $29.9M · modeled $51.0M (est)Celltrio, Inc. · Series A Raised $15.0M · modeled $50.8M (est)Medmo, Inc. · Series A Raised $31.7M · modeled $44.7M (est)Vertical Orthopaedics, Inc. · Series A Raised $16.7M · modeled $44.0M (est)AbriCare, Inc. · Series A Raised $15.0M · modeled $39.1M (est)WP Stillwater, LLC · Series A Raised $14.3M · modeled $38.1M (est)Sylke, Inc. · Series A Raised $15.9M · modeled $37.6M (est)Iridex Corp · Series A Raised $10.0M · modeled $37.2M (est)2GHealth Inc. · Series A Raised $17.5M · modeled $35.6M (est)Okc Alf 4, Llc · Series A Raised $8.9M · modeled $34.5M (est)HC Jones, Inc. · Series A Raised $14.1M · modeled $33.4M (est)Clear Choice ER, LLC (this company) Raised $8.3M · modeled $4.1M (est)Clear Choice ER, LLC
CompanyStageRaised · realValue · estvs peer med.
HelloJoy, Inc.Series A$26.3M$55.0M3.37×
Maui Imaging, Inc.Series A$29.9M$51.0M3.12×
Celltrio, Inc.Series A$15.0M$50.8M3.11×
Medmo, Inc.Series A$31.7M$44.7M2.74×
Vertical Orthopaedics, Inc.Series A$16.7M$44.0M2.69×
AbriCare, Inc.Series A$15.0M$39.1M2.39×
WP Stillwater, LLCSeries A$14.3M$38.1M2.33×
Sylke, Inc.Series A$15.9M$37.6M2.30×
Iridex CorpSeries A$10.0M$37.2M2.28×
2GHealth Inc.Series A$17.5M$35.6M2.18×
Okc Alf 4, LlcSeries A$8.9M$34.5M2.11×
HC Jones, Inc.Series A$14.1M$33.4M2.04×
Clear Choice ER, LLC this companySeries A$8.3M$4.1M0.25×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.2M2019-07-01$6.1M$30.4M90%
Series A$6.0M2024-12-03$27.3M$24.8M90%
Series A$1.1M2025-01-31$4.8M$4.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.2M2019-07-01
    • First recorded raise — entered as Seed.
  2. Series A$6.0M2024-12-03
    • Raised again after 65 mo — slower than the ~14 mo sector norm.
    • Round 4.9× larger than the prior — scaling up.
  3. Series A$1.1M2025-01-31
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 5.7× smaller than the prior — bridge or down round.
Intelligence
2027 ~Q4
Modeled next raise · ~34mo cadence
$1.1M
Modeled next size est.range $1.1M$1.7M
0.2×
Last step-up
$1.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Gerardo Sanchez2 other2024-12
Jacob Puig2 other2019-07
Victor Vasquez, Jr.2 other2024-12
John Puig2025-01
Miguel Solis2025-01
Oscar Buitron2024-12
Robert Flores2025-01
Registry & provenance

Clear Choice ER, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1778196
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Clear Choice Holdco, LLCOther Health CareSeed$2.6M$24.6Mnetwork3 shared operators · same sector
Clear Choice Hospital, LLCHospitals and PhysiciansSeries B$32.8M$7.0Mnetwork3 shared operators
Aqua Heart IncOther Health CareSeries A$8.3M$4.5Msame sector · same stage
Optimvia, LLCOther Health CareSeries A$7.9M$3.4Msame sector · same stage
Exact Imaging Inc.Other Health CareSeries A$7.8M$4.9Msame sector · same stage
MD Professional, LLCOther Health CareSeries A$7.6M$4.5Msame sector · same stage
Lucerno Dynamics, LlcOther Health CareSeries A$9.2M$3.2Msame sector · same stage
Quantum Screening, Inc.Other Health CareSeries A$9.6M$5.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Clear Choice Holdco, LLCOther Health CareSeed$24.6M92%
Clear Choice Hospital, LLCHospitals and PhysiciansSeries B$7.0M89%
Clearstep Inc.Other Health CareSeries A$17.1M85%
Clear Heart & Lung Imaging Corp.Other Health CarePre-Seed$324K85%
Clear Health Pass Holdings LLCHealthtechSeries C$1.8B85%
Imaging Clarity, LLCOther Health CarePre-Seed$229K85%
CLEARFLOW, IncOther Health CareSeries A$6.8M84%
Prescriber's Choice, Inc.Other Health CareSeed$31.8M84%
Frequently asked
How much funding has Clear Choice ER, LLC raised?
Clear Choice ER, LLC has raised approximately $8.3M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Clear Choice ER, LLC's estimated valuation?
Provath's modeled valuation for Clear Choice ER, LLC is approximately $4.1M (modeled range $1.3M–$7.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Clear Choice ER, LLC at?
Clear Choice ER, LLC's latest modeled financing stage is Series A. Its most recent recorded round closed around Fri Jan 31.
What does Clear Choice ER, LLC do and where is it based?
Clear Choice ER, LLC operates in the Other Health Care sector, based in Laredo.
Explore related

See where Clear Choice ER, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Clear Choice ER, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.